rs33954595
| Orientation | minus |
| Stabilized | minus |
| Geno | Mag | Summary |
|---|---|---|
| (G;G) | 0 | common in complete genomics |
| Make rs33954595(A;A) |
| Make rs33954595(A;G) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 11 |
| Position | 5226594 |
| Gene | HBB |
| is a | snp |
| is | mentioned by |
| dbSNP | rs33954595 |
| dbSNP (classic) | rs33954595 |
| ClinGen | rs33954595 |
| ebi | rs33954595 |
| HLI | rs33954595 |
| Exac | rs33954595 |
| Gnomad | rs33954595 |
| Varsome | rs33954595 |
| LitVar | rs33954595 |
| Map | rs33954595 |
| PheGenI | rs33954595 |
| Biobank | rs33954595 |
| 1000 genomes | rs33954595 |
| hgdp | rs33954595 |
| ensembl | rs33954595 |
| geneview | rs33954595 |
| scholar | rs33954595 |
| rs33954595 | |
| pharmgkb | rs33954595 |
| gwascentral | rs33954595 |
| openSNP | rs33954595 |
| 23andMe | rs33954595 |
| SNPshot | rs33954595 |
| SNPdbe | rs33954595 |
| MSV3d | rs33954595 |
| GWAS Ctlg | rs33954595 |
| Max Magnitude | 0 |
| ClinVar | |
|---|---|
| Risk | rs33954595(A;A) rs33954595(C;C) rs33954595(T;T) |
| Alt | rs33954595(A;A) rs33954595(C;C) rs33954595(T;T) |
| Reference | Rs33954595(G;G) |
| Significance | Other |
| Disease | HEMOGLOBIN YPSILANTI HEMOGLOBIN YAKIMA HEMOGLOBIN KEMPSEY |
| Variation | info |
| Gene | HBB |
| CLNDBN | HEMOGLOBIN YPSILANTI HEMOGLOBIN YAKIMA HEMOGLOBIN KEMPSEY |
| Reversed | 1 |
| HGVS | NC_000011.9:g.5247824C>A; NC_000011.9:g.5247824C>G; NC_000011.9:g.5247824C>T |
| CLNSRC | HBVAR OMIM Allelic Variant |
| CLNACC | RCV000016650.4, RCV000016644.2, RCV000016436.2, |
[PMID 235541] The effects of inositol hexaphosphate on the allosteric properties of two beta-99-substituted abnormal hemoglobins, hemoglobin Yakima and hemoglobin Kempsey.
[PMID 4347702] States of hemoglobin in solution.
[PMID 4355556] Nuclear magnetic resonance and spin-label studies of hemoglobin Kempsey.
[PMID 4436316] Functional properties of hemoglobin Kempsey.
[PMID 5651043] Erythrocytosis secondary to increased oxygen affinity of a mutant hemoglobin, hemoglobin Kempsey.
[PMID 667362] 32P and acute leukemia: development of leukemia in a patient with hemoglobin Yakima.
[PMID 6061751
] Hemoglobin Yakina. I. Clinical and biochemical studies.
[PMID 6061752
] Hemoglobin Yakina. II. High blood oxygen affinity associated with compensatory erythrocytosis and normal hemodynamics.
